{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-026428","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2026-08-07T11:00:32+00:00","discovered_at":"2026-08-07T11:05:00.452806+00:00","generated_at":"2026-08-07T11:05:26.305922+00:00","sec_items":["7.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NRx Pharmaceuticals FDA ANDA review: no drug deficiencies; packaging issue to resolve","bullets":["FDA first-round ANDA review for preservative-free ketamine found no major drug-component deficiencies (July 30, 2026).","One major deficiency: twist-off cap on luer lock vial; FDA wants confirmation no patient-safety risk from tip deformation.","Company cited 11.9M doses shipped across 3 approved ANDA products with same vial; 3,500 vials from 7 batches tested with no defects.","Aug 6 clarification meeting with FDA Office of Generic Drugs; FDA requested manufacturer certifications on same lines/machinery, committed to shortest review cycle.","FDA recognizes ketamine as strategic drug on shortage list; management optimistic for first commercial sales in 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-026428","json":"https://secwatch.observer/filing/0001437749-26-026428.json","markdown":"https://secwatch.observer/filing/0001437749-26-026428.md","text":"https://secwatch.observer/filing/0001437749-26-026428.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926026428/0001437749-26-026428-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926026428/nrxp20260806_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-07T11:05:26.305922+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}